Research ArticleCLINICAL INVESTIGATIONS
Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias
Lisa Mosconi, Wai H. Tsui, Karl Herholz, Alberto Pupi, Alexander Drzezga, Giovanni Lucignani, Eric M. Reiman, Vjera Holthoff, Elke Kalbe, Sandro Sorbi, Janine Diehl-Schmid, Robert Perneczky, Francesca Clerici, Richard Caselli, Bettina Beuthien-Baumann, Alexander Kurz, Satoshi Minoshima and Mony J. de Leon
Journal of Nuclear Medicine March 2008, 49 (3) 390-398; DOI: https://doi.org/10.2967/jnumed.107.045385
Lisa Mosconi
Wai H. Tsui
Karl Herholz
Alberto Pupi
Alexander Drzezga
Giovanni Lucignani
Eric M. Reiman
Vjera Holthoff
Elke Kalbe
Sandro Sorbi
Janine Diehl-Schmid
Robert Perneczky
Francesca Clerici
Richard Caselli
Bettina Beuthien-Baumann
Alexander Kurz
Satoshi Minoshima

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 49, Issue 3
March 2008
Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias
Lisa Mosconi, Wai H. Tsui, Karl Herholz, Alberto Pupi, Alexander Drzezga, Giovanni Lucignani, Eric M. Reiman, Vjera Holthoff, Elke Kalbe, Sandro Sorbi, Janine Diehl-Schmid, Robert Perneczky, Francesca Clerici, Richard Caselli, Bettina Beuthien-Baumann, Alexander Kurz, Satoshi Minoshima, Mony J. de Leon
Journal of Nuclear Medicine Mar 2008, 49 (3) 390-398; DOI: 10.2967/jnumed.107.045385
Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias
Lisa Mosconi, Wai H. Tsui, Karl Herholz, Alberto Pupi, Alexander Drzezga, Giovanni Lucignani, Eric M. Reiman, Vjera Holthoff, Elke Kalbe, Sandro Sorbi, Janine Diehl-Schmid, Robert Perneczky, Francesca Clerici, Richard Caselli, Bettina Beuthien-Baumann, Alexander Kurz, Satoshi Minoshima, Mony J. de Leon
Journal of Nuclear Medicine Mar 2008, 49 (3) 390-398; DOI: 10.2967/jnumed.107.045385
Jump to section
Related Articles
Cited By...
- Cerebral hypoperfusion is a late pathological event in the course of Alzheimers disease
- Donor-Specific Transcriptomic Analysis of Alzheimer's Disease-Associated Hypometabolism Highlights a Unique Donor, Ribosomal Proteins and Microglia
- APOE4 Lowers Energy Expenditure and Impairs Glucose Oxidation by Increasing Flux through Aerobic Glycolysis
- Longitudinal structural and metabolic changes in frontotemporal dementia
- Donor specific transcriptomic analysis of Alzheimers disease associated hypometabolism highlights a unique donor, microglia, and ribosomal proteins
- Limits for Reduction of Acquisition Time and Administered Activity in 18F-FDG PET Studies of Alzheimer Dementia and Frontotemporal Dementia
- Neural correlates of exceptional memory ability in SuperAgers: A multimodal approach using FDG-PET, PIB-PET, and MRI
- An evidence-based algorithm for the utility of FDG-PET for diagnosing Alzheimer's disease according to presence of medial temporal lobe atrophy
- Motion discrimination in dementia with Lewy bodies and Alzheimer disease
- Automated Quantification of 18F-Flutemetamol PET Activity for Categorizing Scans as Negative or Positive for Brain Amyloid: Concordance with Visual Image Reads
- Complementary Role of 18F-FDG PET and 123I-Ioflupane SPECT in the Diagnosis of Lewy Body Disease
- Systematic Comparison of the Performance of Integrated Whole-Body PET/MR Imaging to Conventional PET/CT for 18F-FDG Brain Imaging in Patients Examined for Suspected Dementia
- [18F]FDG-PET is superior to [123I]IBZM-SPECT for the differential diagnosis of parkinsonism
- Nuclear medicine functional imaging of the brain
- Inclusion criteria provide heterogeneity in baseline profiles of patients with mild cognitive impairment: comparison of two prospective cohort studies
- Brain Imaging in Alzheimer Disease
- Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent Literature
- Target-Specific PET Probes for Neurodegenerative Disorders Related to Dementia
- Combining MR Imaging, Positron-Emission Tomography, and CSF Biomarkers in the Diagnosis and Prognosis of Alzheimer Disease